Skip to main content

News

By Susan Morse | 04:56 pm | February 27, 2025
A HIMSS25 session on a cybersecurity strategy features experts from the Cleveland Clinic and Clearwater.
By Susan Morse | 11:23 am | February 27, 2025
A federal judge ordered CVS to comply, but CVS objects to the order and deadline.
By Jeff Lagasse | 10:57 am | February 27, 2025
The administration is decrying what it calls "hidden" prices and "opaque" pricing arrangements.
By Susan Morse | 11:23 am | February 26, 2025
Letter to CEO Andrew Witty follows report of DOJ launching investigation into the company's billing methods.
By Susan Morse | 10:04 am | February 26, 2025
HIMSS25 session will show how leveraging AI improves data accuracy and operational efficiency while minimizing manual efforts. 
By Jeff Lagasse | 07:33 pm | February 25, 2025
A U.S. district judge said Trump's executive orders relating to DEI likely violate the Constitution.
By Susan Morse | 11:11 am | February 25, 2025
The FTC alleges anticompetitive and unfair rebating practices that artificially inflate the list price of insulin.
By Jeff Lagasse | 10:59 am | February 25, 2025
During Theodorescu's tenure, Cedars-Sinai Cancer doubled its NIH funding and expanded the scope of its research.
By Jeff Lagasse | 09:24 am | February 25, 2025
Sponsors say a pathway is important because many cancers currently lack an effective screening option.
By Susan Morse | 10:58 am | February 24, 2025
The FTC maintains that PBMs systematically prefer high list price insulin products with high rebates and fees over low list products.